Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stempeucel in STEMI
NCT00883727Phase 2Completed
- Sponsor
- Stempeutics Research
- Start
- Apr 2009
- Primary completion
- May 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Stempeucel with Placebo (2 arms). Primary endpoint: Adverse Events and ECG parameters at 6 months. Started Apr 2009; status: completed.
02
Drugs
Stempeucel
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00883727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883727.